Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Sparc testing confirms graphene as vital additive to prevent corrosion
    • News

    Sparc testing confirms graphene as vital additive to prevent corrosion

    Graphene continues to emerge as one of the world’s most innovative materials of the future following test work by Sparc Technologies (ASX: SPN) confirming its significant performance as a protective layer that can prevent corrosion. The testing, which was performed with the University of Adelaide, saw graphene-based additives applied to various steel panels. Over 10

    Read More
    Public
  • AV uptake leads Audinate to push European expansion through recruiting drive
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive

    A reliance on digital connectivity through the pandemic has seen rising adoption of audio tech from Audinate (ASX: AD8) as they see continued uptake of their transformational audio-visual solutions that are disrupting the need for traditional hardware devices. Reporting revenue of USD $11.1 million (unaudited) for the half-year ending 31 December 2020, Audinate’s Dante® media

    Read More
    Public
  • Bottoming longer-term rates, record prices, stagnant profits: Will the share market rally end in 2021?
    • Opinion

    Bottoming longer-term rates, record prices, stagnant profits: Will the share market rally end in 2021?

    Predicting a crash can be very difficult. Many of the professional investors who called the last major crashes also predicted other crashes that never eventuated. What we do know for sure, is that there are times when share prices are cheap, and times when they are expensive. US Share prices have never been more expensive

    Read More
    Public
  • JAT Corp to open first China retail gateway following 12 month COVID delay
    • News

    JAT Corp to open first China retail gateway following 12 month COVID delay

    It’s been a frustrating wait for dairy products company JAT Corp (ASX: JAT) but the China-focused exporter is set to finally open their first retail store in Shanghai having predominantly relied on distributors and online channels through the pandemic. Originally set to open in March 2020 as JAT Corp’s (previously Jatenergy) flagship retail store, the

    Read More
    Public
  • Quickfire FDA approval for Acrux’s testosterone sends share price soaring
    • News

    Quickfire FDA approval for Acrux’s testosterone sends share price soaring

    Aussie pharmaceuticals company Acrux (ASX: ACR) is quickly making inroads through the lucrative American healthcare system with regulatory approval granted for their generic equivalent of a common testosterone topical solution which generates more than $25 million annually. Approval was granted from the Food and Drug administration for Acrux’s gel following their submission in August 2018

    Read More
    Public
  • Shunning of public transport sends Wisr’s car loans vrooming
    • News

    Shunning of public transport sends Wisr’s car loans vrooming

    Amid the many ways COVID-19 has brought about new business opportunities, financing fintech company Wisr (ASX: WZR) continues to benefit from Aussies being more financially responsible through the pandemic, reporting a 35% increase in loan originations, driven by vehicle financing. For the quarter ending 31 December 2020, Wisr continued its upward momentum to deliver its

    Read More
    Public
  • «
  • ‹
  • 541
  • 542
  • 543
  • 544
  • 545
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.